{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T13:22:01Z","timestamp":1762608121149,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.msard.2020.102702","type":"journal-article","created":{"date-parts":[[2020,12,19]],"date-time":"2020-12-19T12:01:42Z","timestamp":1608379302000},"page":"102702","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Experience of South American MS and\/or NMOSD experts in practice during the COVID-19 pandemic: Focus on Telemedicine"],"prefix":"10.1016","volume":"48","author":[{"given":"Ricardo","family":"Alonso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3583-8412","authenticated-orcid":false,"given":"Ren\u00e9","family":"Carvajal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mateus","family":"Boaventura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorna","family":"Galleguillos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2020.102702_bib0001","unstructured":"American Academy of Neurology, 2020. Telemedicine and remote care [WWW Document]. URL https:\/\/www.aan.com\/siteassets\/home-page\/tools-and-resources\/practicing-neurologist\u2013administrators\/telemedicine-and-remote-care\/20-telemedicine-and-covid19-v103.pdf (accessed 4.14.20)."},{"key":"10.1016\/j.msard.2020.102702_bib0002","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1177\/1352458518793527","article-title":"Toward a low-cost, in-home, telemedicine-enabled assessment of disability in multiple sclerosis","volume":"25","author":"Bove","year":"2019","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2020.102702_bib0003","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000009507","article-title":"Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic","author":"Brownlee","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2020.102702_bib0004","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006921.pub3","article-title":"Oral versus intravenous steroids for treatment of relapses in multiple sclerosis","author":"Burton","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.msard.2020.102702_bib0005","first-page":"157","article-title":"WHO declares COVID-19 a pandemic","volume":"91","author":"Cucinotta","year":"2020","journal-title":"Acta Biomed"},{"key":"10.1016\/j.msard.2020.102702_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102073","article-title":"The COVID-19 pandemic and the use of MS disease-modifying therapies","volume":"39","author":"Giovannoni","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2020.102702_bib0007","doi-asserted-by":"crossref","first-page":"169","DOI":"10.7861\/clinmedicine.19-2-169","article-title":"Neuromyelitis optica spectrum disorders","volume":"19","author":"Huda","year":"2019","journal-title":"Clin. Med. (Northfield. Il)."},{"key":"10.1016\/j.msard.2020.102702_bib0008","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1258\/135763307781645202","article-title":"Review of the use of telemedicine in South America","volume":"13","author":"Keane","year":"2007","journal-title":"J. Telemed. Telecare"},{"key":"10.1016\/j.msard.2020.102702_bib0009","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.msard.2017.09.027","article-title":"Validity and reproducibility of the Italian version of the patient determined disease steps scale in people with multiple sclerosis","volume":"18","author":"Lavorgna","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2020.102702_bib0010","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0140-6736(15)61137-0","article-title":"Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): A randomised, controlled, double-blind, non-inferiority trial","volume":"386","author":"Le Page","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.msard.2020.102702_bib0011","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2377-13-37","article-title":"Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis","volume":"13","author":"Learmonth","year":"2013","journal-title":"BMC Neurol"},{"key":"10.1016\/j.msard.2020.102702_bib0012","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/dewb.12262","article-title":"Latin American healthcare systems in times of pandemic","volume":"20","author":"Litewka","year":"2020","journal-title":"Dev. World Bioeth."},{"key":"10.1016\/j.msard.2020.102702_bib0013","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s10072-020-04470-x","article-title":"Assessing disability and relapses in multiple sclerosis on tele-neurology","volume":"41","author":"Moccia","year":"2020","journal-title":"Neurol. Sci."},{"year":"2020","series-title":"The coronavirus and MS \u2013 updated global advice","key":"10.1016\/j.msard.2020.102702_bib0014"},{"key":"10.1016\/j.msard.2020.102702_bib0015","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1212\/CON.0000000000000739","article-title":"Management of multiple sclerosis relapses","volume":"25","author":"Repovic","year":"2019","journal-title":"Contin. Lifelong Learn. Neurol."},{"key":"10.1016\/j.msard.2020.102702_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102310","article-title":"Decision-making on management of ms and nmosd patients during the COVID-19 pandemic: A latin american survey","volume":"44","author":"Ricardo","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2020.102702_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2020.101613","article-title":"COVID-19 in Latin America: The implications of the first confirmed case in Brazil","author":"Rodriguez-Morales","year":"2020","journal-title":"Travel Med. Infect. Dis."},{"key":"10.1016\/j.msard.2020.102702_bib0018","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1212\/WNL.0000000000009844","article-title":"Initial experiences of US neurologists in practice during the COVID-19 pandemic via survey","volume":"95","author":"Sharma","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2020.102702_bib0019","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.msard.2018.01.014","article-title":"Symbol Digit Modalities Test adaptation for Magnetic Resonance Imaging environment: A systematic review and meta-analysis","volume":"20","author":"Silva","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2020.102702_bib0020","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nrneurol.2017.171","article-title":"Assessing treatment outcomes in multiple sclerosis trials and in the clinical setting","volume":"14","author":"Tur","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.msard.2020.102702_bib0021","article-title":"Telemedicine and Multiple Sclerosis: A Comprehensive Literature Review","author":"Yeroushalmi","year":"2019","journal-title":"J. Telemed. Telecare."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034820307768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034820307768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:54:12Z","timestamp":1761900852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034820307768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":21,"alternative-id":["S2211034820307768"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2020.102702","relation":{},"ISSN":["2211-0348"],"issn-type":[{"type":"print","value":"2211-0348"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Experience of South American MS and\/or NMOSD experts in practice during the COVID-19 pandemic: Focus on Telemedicine","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2020.102702","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102702"}}